| Literature DB >> 34934102 |
Chenguang Wang1,2, Luxi Xu1,2, Xiaoyu Liang1,2, Jing Wang1,2, Xinwei Xian1,2, Yu Zhang1,2, Ye Yang3,4.
Abstract
Stem-end rot (SER) caused by Lasiodiplodia theobromae is an important disease of mango in China. Demethylation inhibitor (DMI) fungicides are widely used for disease control in mango orchards. The baseline sensitivity to difenoconazole of 138 L. theobromae isolates collected from mango in the field in 2019 was established by the mycelial growth rate method. The cross-resistance to six site-specific fungicides with different modes of action were investigated using 20 isolates randomly selected. The possible mechanism for L. theobromae resistance to difenoconazole was preliminarily determined through gene sequence alignment and quantitative real-time PCR analysis. The results showed that the EC50 values of 138 L. theobromae isolates to difenoconazole ranged from 0.01 to 13.72 µg/mL. The frequency of difenoconazole sensitivity formed a normal distribution curve when the outliers were excluded. Difenoconazole showed positive cross-resistance only with the DMI tebuconazole but not with non-DMI fungicides carbendazim, pyraclostrobin, fludioxonil, bromothalonil, or iprodione. Some multifungicide-resistant isolates of L. theobromae were found. Two amino acid substitutions (E209k and G207A) were found in the CYP51 protein, but they were unlikely to be related to the resistance phenotype. There was no alteration in the promoter region of the CYP51 gene. However, difenoconazole significantly increased the expression of the CYP51 gene in the resistant isolates compared to the susceptible isolates. These results are vital to develop effective mango disease management strategies to avoid the development of further resistance.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34934102 PMCID: PMC8692403 DOI: 10.1038/s41598-021-03601-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Primers utilized in this study.
| Primers | Sequence (5′ → 3′) | Description |
|---|---|---|
| Per-1F | GCCAACAGCCACGGATGAT | Amplification of the promoter region of the Lt CYP51 gene |
| Per-1R | GCCATAGGTGACGGTGCTG | |
| Lt-CYP51F | CCCTCCGTCTCCCTACACCT | Amplification of the coding region of the Lt CYP51 gene |
| Lt-CYP51R | TTCTCCCTCCTCTCCCAAA | |
| RT-LtF | GGATTGTGCTTCGTCTCGC | Quantitative RT-PCR primers for analysis of Lt CYP51 expression |
| RT-LtR | CGTCTCCTTGACCACCTGCT | |
| RT-Act LtF | GGAGATGAGGCACAGTCG | Amplification of the actin gene |
| RT-Act LtR | GCGGTGGTGGAGAAAGAGT |
The EC50 values of Lasiodiplodia theobromae isolates to seven fungicides.
| Isolates | EC50 ± SD (µg/mL)a | ||||||
|---|---|---|---|---|---|---|---|
| Difb | Car | Pyr | Flu | Bro | Ipr | Teb | |
| YC80 | 7.59 ± 0.23 | 8016.29 ± 658.34 | 1913.83 ± 158.46 | 0.04 ± 0.01 | 11.68 ± 1.92 | 0.30 ± 0.06 | 0.97 ± 0.11 |
| SY06 | 9.63 ± 0.66 | 3.37 ± 0.28 | 1.75 ± 0.25 | 0.08 ± 0.01 | 9.52 ± 1.27 | 0.53 ± 0.09 | 1.87 ± 0.13 |
| LD13 | 1.99 ± 0.22 | 0.02 ± 0.01 | 344.93 ± 45.72 | 0.17 ± 0.02 | 14.89 ± 1.63 | 0.36 ± 0.05 | 0.33 ± 0.08 |
| SY34 | 10.14 ± 0.91 | 1792.64 ± 176.28 | 213.41 ± 19.33 | 0.04 ± 0.01 | 10.02 ± 1.15 | 0.23 ± 0.06 | 1.11 ± 0.09 |
| YC70 | 0.97 ± 0.52 | 0.09 ± 0.01 | 79 ± 5.38 | 0.03 ± 0.01 | 2.08 ± 0.46 | 0.23 ± 0.07 | 0.07 ± 0.01 |
| SY05 | 6.52 ± 0.40 | 0.38 ± 0.02 | 260.01 ± 19.62 | 0.05 ± 0.01 | 7.83 ± 0.98 | 0.37 ± 0.08 | 0.68 ± 0.07 |
| SY31 | 6.24 ± 0.33 | 1.08 ± 0.14 | 83.21 ± 8.45 | 0.26 ± 0.03 | 5.04 ± 0.56 | 0.25 ± 0.09 | 0.60 ± 0.08 |
| DZ11 | 8.29 ± 0.36 | 2.68 ± 0.38 | 429.48 ± 47.83 | 0.04 ± 0.01 | 5.33 ± 0.40 | 0.40 ± 0.06 | 0.84 ± 0.09 |
| AM82 | 1.03 ± 0.85 | 5447.84 ± 529.11 | 210.77 ± 20.45 | 0.11 ± 0.02 | 7.33 ± 0.72 | 0.54 ± 0.08 | 0.17 ± 0.02 |
| YZ31 | 7.22 ± 0.63 | 8.39 ± 0.96 | 133.87 ± 11.23 | 0.06 ± 0.01 | 6.46 ± 0.75 | 0.42 ± 0.03 | 0.81 ± 0.09 |
| CJ20 | 2.61 ± 0.57 | 0.0001 ± 0.00 | 25.9 ± 1.99 | 0.11 ± 0.02 | 8.90 ± 0.66 | 0.23 ± 0.05 | 0.47 ± 0.06 |
| YZ01 | 5.39 ± 0.92 | 1.17 ± 0.16 | 8.09 ± 0.93 | 0.09 ± 0.01 | 7.36 ± 0.97 | 0.32 ± 0.04 | 0.42 ± 0.05 |
| CJ01 | 0.73 ± 0.33 | 0.52 ± 0.04 | 54.02 ± 6.35 | 0.15 ± 0.02 | 10.54 ± 0.94 | 0.30 ± 0.04 | 0.40 ± 0.07 |
| AM24 | 2.22 ± 0.30 | 1.15 ± 0.12 | 9.98 ± 1.21 | 0.10 ± 0.01 | 8.90 ± 0.81 | 0.25 ± 0.16 | 0.40 ± 0.06 |
| SY26 | 8.53 ± 1.17 | 1.05 ± 0.10 | 6.07 ± 0.78 | 0.21 ± 0.03 | 6.07 ± 0.83 | 0.35 ± 0.19 | 0.98 ± 0.08 |
| LD34 | 0.33 ± 0.29 | 0.68 ± 0.05 | 16.58 ± 1.75 | 0.08 ± 0.01 | 16.58 ± 1.74 | 0.42 ± 0.05 | 0.89 ± 0.09 |
| LD10 | 6.64 ± 0.41 | 8537.14 ± 721.73 | 230.67 ± 20.65 | 0.12 ± 0.02 | 9.16 ± 0.95 | 0.25 ± 0.07 | 0.63 ± 0.09 |
| SY02 | 11.56 ± 0.72 | 2.63 ± 0.45 | 58.36 ± 4.92 | 0.17 ± 0.05 | 8.05 ± 0.75 | 0.31 ± 0.09 | 1.59 ± 0.03 |
| JS10 | 0.65 ± 0.22 | 1.32 ± 0.23 | 211.39 ± 19.43 | 0.05 ± 0.01 | 8.45 ± 0.92 | 0.31 ± 0.08 | 0.07 ± 0.01 |
| YZ90 | 9.34 ± 0.20 | 5.59 ± 0.46 | 0.0008 ± 0.00 | 0.03 ± 0.01 | 5.59 ± 0.63 | 0.36 ± 0.09 | 0.98 ± 0.09 |
aValues in a column indicate EC50 means ± standard deviation (SD).
bDif difenoconazole, Car carbendazim, Pyr pyraclostrobin, Flu fludioxonil, Bro bromothalonil, Ipr iprodione, Teb tebuconazole.
Figure 1Frequency distribution of lg (EC50) values of difenoconazole against 121 Lasiodiplodia theobromae isolates when the outliers were excluded.
Figure 2Mycelia colony growth of the eight Lasiodiplodia theobromae isolates on PDA plates with and without difenoconazole.
Figure 3Cross-resistance between difenoconazole and carbendazim (A), pyraclostrobin (B), fludioxonil (C), bromothalonil (D), iprodione (E), tebuconazole (F) by rank correlation analysis. Data shown in logarithmic values of EC50 among Lasiodiplodia theobromae for fungicide combinations.
Figure 4Partial sequences and deduced amino acid sequences of the LtCYP51 gene from sensitive Lasiodiplodia theobromae isolates YC70 (Accession number: MZ365052).The intron sequence is depicted in a solid line box with an arrow showing the insertion site. Two amino acid substitutions were found at position 207 and 209 (in blue box).
Figure 5Expression of Ltcyp51 in the sensitive and resistant isolates of Lasiodiplodia theobromae before and after treated by difenoconazole. (A) Changes of relative expression levels of 8 isolates; (B) changes of the mean relative expression levels of different phenotype. **represent significant level (P < 0.01), ***represents significant level (P < 0.001).